Blood test holds promise for early liver cancer detection
NCT ID NCT02908048
First seen May 07, 2026 · Last updated May 07, 2026
Summary
This study aimed to see if tiny genetic particles in the blood, called extracellular RNA, could help diagnose liver cancer or other liver diseases. Researchers planned to enroll about 1,865 people with liver cancer, cirrhosis, or chronic liver disease. The goal was to find out if these blood markers could also predict how well treatment works or if cancer comes back after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Mayo Clinic Florida
Jacksonville, Florida, 32224, United States
-
McGuire VA Medical Center
Richmond, Virginia, 23249, United States
-
The University of Chicago Medical Center
Chicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.